124 related articles for article (PubMed ID: 2711284)
41. [The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome].
Aul C; Germing U; Gattermann N; Söhngen D; Heyll A
Dtsch Med Wochenschr; 1996 Sep; 121(37):1113-8. PubMed ID: 8925725
[TBL] [Abstract][Full Text] [Related]
42. Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes.
Alexandrakis MG; Passam FH; Pappa CA; Sfiridaki K; Tsirakis G; Damilakis J; Stathopoulos EN; Kyriakou DS
Leuk Res; 2005 Jan; 29(1):41-6. PubMed ID: 15541473
[TBL] [Abstract][Full Text] [Related]
43. Mean corpuscular volume predicts prognosis in MDS patients with abnormal karyotypes.
Wang H; Wang X; Xu X; Lin G
Ann Hematol; 2010 Jul; 89(7):671-9. PubMed ID: 20179929
[TBL] [Abstract][Full Text] [Related]
44. Prognostic factors of myelodysplastic syndromes--a simplified 3-D scoring system.
Goasguen JE; Garand R; Bizet M; Bremond JL; Gardais J; Callat MP; Accard F; Chaperon J
Leuk Res; 1990; 14(3):255-62. PubMed ID: 2319806
[TBL] [Abstract][Full Text] [Related]
45. Myelodysplastic syndromes: analysis of clinical and prognostic features in 96 patients.
van der Weide M; Sizoo W; Nauta JJ; Krefft J; Langenhuijsen MM
Eur J Haematol; 1988 Aug; 41(2):115-22. PubMed ID: 3165865
[TBL] [Abstract][Full Text] [Related]
46. Clinico-pathological analysis of myelodysplastic syndromes according to French-American-British classification and international prognostic scoring system.
Lau LG; Chng WJ; Liu TC; Tan LK; Ong KH; Mow BM; Kueh YK
Ann Acad Med Singap; 2004 Sep; 33(5):589-95. PubMed ID: 15531954
[TBL] [Abstract][Full Text] [Related]
47. High frequency of human leukocyte antigen class II DRB1*1602 haplotype in Greek patients with myelodysplastic syndrome and of DRB1*1501 in the low-risk subgroup.
Kritikou-Griva E; Spyropoulou-Vlachou M; Tsagarakis NJ; Goumakou E; Vrani V; Galanopoulos A; Papadhimitriou SI; Androutsos G; Paterakis G; Stavropoulos-Giokas C
Hum Immunol; 2012 Mar; 73(3):278-81. PubMed ID: 22244918
[TBL] [Abstract][Full Text] [Related]
48. Primary myelodysplastic syndrome: an analysis of 56 patients.
Chen PH; Kuo CY; Huang CH; Shih LY
Changgeng Yi Xue Za Zhi; 1992 Sep; 15(3):121-7. PubMed ID: 1468034
[TBL] [Abstract][Full Text] [Related]
49. Myelodysplastic syndromes: a multiparametric study of prognostic factors and a proposed scoring system.
Cassano E; Giordano M; Riccardi A; Coci A; Cazzola M
Haematologica; 1990; 75(2):141-5. PubMed ID: 2358204
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the prognostic significance of eosinophilia and basophilia in a larger cohort of patients with myelodysplastic syndromes.
Wimazal F; Germing U; Kundi M; Noesslinger T; Blum S; Geissler P; Baumgartner C; Pfeilstoecker M; Valent P; Sperr WR
Cancer; 2010 May; 116(10):2372-81. PubMed ID: 20209617
[TBL] [Abstract][Full Text] [Related]
51. Risk factors of myelodysplastic syndromes: a case-control study.
Strom SS; Gu Y; Gruschkus SK; Pierce SA; Estey EH
Leukemia; 2005 Nov; 19(11):1912-8. PubMed ID: 16167059
[TBL] [Abstract][Full Text] [Related]
52. [Analysis of 259 patients with myelodysplastic syndromes. The Czechoslovak MDS Cooperative Group].
Cas Lek Cesk; 1990 Jul; 129(28):865-71. PubMed ID: 2253265
[TBL] [Abstract][Full Text] [Related]
53. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases.
Foucar K; Langdon RM; Armitage JO; Olson DB; Carroll TJ
Cancer; 1985 Aug; 56(3):553-61. PubMed ID: 3891071
[TBL] [Abstract][Full Text] [Related]
54. Life expectancy in primary myelodysplastic syndromes: a prognostic score based upon histopathology from bone marrow biopsies of 569 patients.
Maschek H; Gutzmer R; Choritz H; Georgii A
Eur J Haematol; 1994 Nov; 53(5):280-7. PubMed ID: 7813708
[TBL] [Abstract][Full Text] [Related]
55. Primary myelodysplastic syndrome: clinical spectrum of 53 cases.
Irfan M; Kakepoto GN; Khursheed M
J Pak Med Assoc; 1998 Mar; 48(3):69-73. PubMed ID: 9783031
[TBL] [Abstract][Full Text] [Related]
56. The myelodysplastic syndrome: prognostic factors in relation to the "in vitro" clonogenic assay.
Bianchi de Di Risio CC; Gronda M; Malka A; Barbich M; Santarelli MT
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):141-50. PubMed ID: 1695168
[TBL] [Abstract][Full Text] [Related]
57. Myelodysplastic syndromes--a population-based study on transformation and survival.
Hörnsten P; Wahlin A; Rudolphi O; Nordenson I
Acta Oncol; 1995; 34(4):473-8. PubMed ID: 7605654
[TBL] [Abstract][Full Text] [Related]
58. Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare.
Oguma S; Yoshida Y; Uchino H; Maekawa T; Nomura T; Mizoguchi H
Leuk Res; 1995 Mar; 19(3):219-25. PubMed ID: 7700083
[TBL] [Abstract][Full Text] [Related]
59. The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome.
Cordoba I; Gonzalez-Porras JR; Such E; Nomdedeu B; Luño E; de Paz R; Carbonell F; Vallespi T; Ardanaz M; Ramos F; Marco V; Bonanad S; Sanchez-Barba M; Costa D; Bernal T; Sanz GF; Cañizo MC
Leuk Res; 2012 Mar; 36(3):287-92. PubMed ID: 22133642
[TBL] [Abstract][Full Text] [Related]
60. Serum tryptase measurements in patients with myelodysplastic syndromes.
Sperr WR; Stehberger B; Wimazal F; Baghestanian M; Schwartz LB; Kundi M; Semper H; Jordan JH; Chott A; Drach J; Jäger U; Geissler K; Greschniok A; Horny HP; Lechner K; Valent P
Leuk Lymphoma; 2002 May; 43(5):1097-105. PubMed ID: 12148892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
